Expression of p53, p21CIP1/WAF1 and eIF4E in the adjacent tissues of oral squamous cell carcinoma: Establishing the molecular boundary and a cancer progression model

International Journal of Oral Science

Volumn 7, Issue 3, 2015, Pages 161-168

  Li, Yi ^a   Li, Bo ^a   Xu, Bo ^a,b   Han, Bo ^a   Xia, Hui ^a   Chen, Qian Ming ^a   Li, Long Jiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b The Central Hospital of Panzhihua city   (China)

Author keywords

eIF4E; Molecular boundary; Oral squamous cell carcinoma; P21; P53

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INITIATION FACTOR 4E; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; AGED; DISEASE COURSE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84941761977     PISSN: 16742818     EISSN: 20493169     Source Type: Journal    
DOI: 10.1038/ijos.2015.5     Document Type: Article

References (41)

1. McDowell JD An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am 2006; 39(2): 277-294.
2. Yanamoto S, Yamada S, Takahashi H et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2012; 41(10): 1195-1200.
3. Guillemaud JP, Patel RS, Goldstein DP et al. Prognostic impact of intraoperative microscopic cut-through on frozen section in oral cavity squamous cell carcinoma. J Otolaryngol Head Neck Surg 2010; 39(4): 370-377.
4. Brandwein-Gensler M, Teixeira MS, Lewis CM et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29(2): 167-178.
5. Lyons AJ, Jones J. Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg 2007; 36(8): 671-679.
6. Jacobs JR, Ahmad K, Casiano R et al. Implications of positive surgical margins. Laryngoscope 1993; 103(1 Pt 1): 64-68.
7. Dolcetti R, Doglioni C, Maestro R et al. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer 1992; 52(2): 178-182.
8. Curran AJ, St Denis K, Irish J et al. Telomerase activity in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124(7): 784-788.
9. Gale N, Plich BZ, Sidransky D et al. Tumours of the hypopharynx, larynx and trachea (Epithelial precursor lesions) // Barnes L, Eveson JW, Reichart P et al. eds. World Health Organization Classification of Tumours Pathology & Genetics Head and Neck Tumours International Agency for Research on Cancer (IARC). Lyon: IARC Press, 2005: 140-143.
10. Stark AM, Hugo HH, Tscheslog H et al. p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques. Neurol Res 2007; 29(5): 435-440.
11. Schindlbeck C, Hantschmann P, Zerzer M et al. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow. Int J Gynecol Cancer 2007; 17(5): 1047-1055.
12. Chiou WY, Lin HY, Hsu FC et al. Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence. Radiat Oncol 2010; 5: 79.
13. Ota Y, Aoki T, Karakida K et al. Determination of deep surgical margin based on anatomical architecture for local control of squamous cell carcinoma of the buccal mucosa. Oral Oncol 2009; 45(7): 605-609.
14. Ngoi SS, Staiano-Coico L, Godwin TA et al. Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer. Cancer 1990; 66(5): 953-959.
15. Hoffmann TK, Bier H, Donnenberg AD et al. p53 as an immunotherapeutic target in head and neck cancer. Adv Otorhinolaryngol 2005; 62: 151-160.
16. Carlos de Vicente J, Junquera Gutiérrez LM, Zapatero AH et al. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck 2004; 26(1): 22-30.
17. Heah KG, Hassan MI, Huat SC. p53 expression as a marker of microinvasion in oral squamous cell carcinoma. Asian Pac J Cancer Prev 2011; 12(4): 1017-1022.
18. Kato K, Kawashiri S, Yoshizawa K et al. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. J Oral Pathol Med 2011; 40(9): 693-698.
19. Perisanidis C, Perisanidis B, Wrba F et al. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. J Oral Pathol Med 2012; 41(1): 40-46.
20. Allegra E, Puzzo L, Cutrona D et al. p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma. Acta Otorhinolaryngol Ital 2003; 23(6): 454-458.
21. el-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75(4): 817-825.
22. Harper JW, Adami GR, Wei N et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75(4): 805-816.
23. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005; 65(10): 3980-3985.
24. Bedelbaeva K, Snyder A, Gourevitch D et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl Acad Sci U S A 2010; 107 (13): 5845-5850.
25. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004; 23(18): 3189-3199.
26. Nathan CO, Franklin S, Abreo FW et al. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol 1999; 17(9): 2909-2914.
27. Sunavala-Dossabhoy G, Palaniyandi S, Clark C et al. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer. Laryngoscope 2011; 121(10): 2136-2141.
28. Sorrells DL Jr, Ghali GE, de Benedetti A et al. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg 1999; 57(3): 294-299.
29. Franklin S, Pho T, Abreo FW et al. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers. Arch Otolaryngol Head Neck Surg 1999; 125(2): 177-182.
30. Nathan CO, Amirghahri N, Rice C et al. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002; 112(12): 2129-2140.
31. Babichenko II, Rabinovich OF, Ivina AA et al. [Papillomavirus in the genesis of oral leukoplakia.] Arkh Patol 2014; 76(1): 32-36. Russian.
32. Myoung H, Kim MJ, Lee JH et al. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 2006; 35(11): 1005-1010.
33. Akino T, Hida K, Hida Y et al. Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors. Am J Pathol 2009; 175(6): 2657-2667.
34. Romics I, Bocsi J, Bach D et al. DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomy. Anticancer Res 1995; 15(3): 1131-1134.
35. Bignold LP Mutation, replicative infidelity of DNA and aneuploidy sequentially in the formation of malignant pleomorphic tumors. Histol Histopathol 2007; 22(3): 321-326.
36. Abou-Elhamd KE, Habib TN. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncol 2007; 43(4): 366-372.
37. Marur S, D'Souza G, Westra WH et al. HPV-associated head and neck cancer: a virusrelated cancer epidemic. Lancet Oncol 2010; 11(8): 781-789.
38. Kero K, Rautava J, Syrjänen K et al. Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol 2012; 62(6): 1063-1070.
39. Ruttkay-Nedecky B, Jimenez Jimenez AM, Nejdl L et al. Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review). Int J Oncol 2013; 43(6): 1754-1762.
40. Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991; 10(13): 4129-4135.
41. Gillison ML, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100(6): 407-420.